LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 2 von insgesamt 2

Suchoptionen

  1. Artikel ; Online: Personalized Management of Sodium and Volume Imbalance in Hemodialysis to Mitigate High Costs of Hospitalization.

    Hornig, Carsten / Canaud, Bernard J M / Bowry, Sudhir Kumar

    Blood purification

    2023  Band 52, Heft 6, Seite(n) 564–577

    Abstract: The primary objective of hemodialysis (HD) is lowering concentrations of organic uremic toxins that accumulate in blood in end-stage kidney disease (ESKD) and redress imbalances of inorganic compounds in particular sodium and water. Removal by ... ...

    Abstract The primary objective of hemodialysis (HD) is lowering concentrations of organic uremic toxins that accumulate in blood in end-stage kidney disease (ESKD) and redress imbalances of inorganic compounds in particular sodium and water. Removal by ultrafiltration of excess fluid that has accumulated during the dialysis-free interval is a vital aspect of each HD session. Most HD patients are volume overloaded, with ∼25% of patients having severe (>2.5 L) fluid overload (FO). The potentially serious complications of FO contribute to the high cardiovascular morbidity and mortality observed in the HD population. Weekly cycles imposed by the schedule of HD treatments create a deleterious and unphysiological "tide phenomenon" marked by sodium-volume overload (loading) and depletion (unloading). Fluid overload-related hospitalizations are frequent and costly, with average cost estimates of $ 6,372 per episode, amounting to some $ 266 million total costs over a 2-year period in a US dialysis population. Various strategies (e.g., dry weight management or use of fluids with different sodium concentrations) have been attempted to rectify FO in HD patients but have met with limited success largely due to imprecise and cumbersome, or costly, approaches. In recent years, conductivity-based technologies have been refined to actively restore sodium and fluid imbalance and maintain the predialysis plasma sodium set point (plasma tonicity) of each patient. By automatically controlling the dialysate-plasma sodium gradient based on the specific patient needs throughout a session, an individualized sodium dialysate prescription can be delivered. Maintaining precise sodium mass balance helps better control of blood pressure, reduces FO, and thus tends to prevent hospitalization for congestive heart failure. We present the case for personalized salt and fluid management via a machine-integrated sodium management tool. Results from proof-of-principle clinical trials indicate that the tool enables individualized sodium-fluid volume control during each HD session. Its application in routine clinical practice has the potential to mitigate the substantial economic burden of hospitalizations attributed to volume overload complications in HD. Additionally, such a tool would contribute toward reduced symptomology and dialysis-induced multiorgan damage in HD patients and to improving their treatment perception and quality of life which matters most to patients.
    Mesh-Begriff(e) Humans ; Sodium ; Quality of Life ; Renal Dialysis/adverse effects ; Renal Dialysis/methods ; Kidney Failure, Chronic ; Dialysis Solutions ; Water-Electrolyte Imbalance/etiology ; Water-Electrolyte Imbalance/prevention & control ; Heart Failure/complications
    Chemische Substanzen Sodium (9NEZ333N27) ; Dialysis Solutions
    Sprache Englisch
    Erscheinungsdatum 2023-06-08
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article ; Review
    ZDB-ID 605548-5
    ISSN 1421-9735 ; 0253-5068
    ISSN (online) 1421-9735
    ISSN 0253-5068
    DOI 10.1159/000530816
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Changing paradigms of renal replacement therapy in chronic kidney disease patients: ultrapure dialysis fluid and high-efficiency hemodiafiltration for all?

    Canaud, Bernard J M

    Kidney international

    2009  Band 76, Heft 6, Seite(n) 591–593

    Abstract: Ultrapurity of dialysis fluid is important for the biocompatibility of renal replacement therapy systems. Penne and collaborators have assessed the microbiological quality of water and dialysis fluid in dialysis facilities. No side effects were noted in ... ...

    Abstract Ultrapurity of dialysis fluid is important for the biocompatibility of renal replacement therapy systems. Penne and collaborators have assessed the microbiological quality of water and dialysis fluid in dialysis facilities. No side effects were noted in 97 patients who received 11,258 online hemodiafiltration sessions. This study confirms that ultrapure water and dialysis fluid may be easily produced and used for online hemodiafiltration.
    Mesh-Begriff(e) Dialysis Solutions/standards ; Hemodiafiltration/standards ; Humans ; Kidney Failure, Chronic/therapy ; beta 2-Microglobulin/blood
    Chemische Substanzen Dialysis Solutions ; beta 2-Microglobulin
    Sprache Englisch
    Erscheinungsdatum 2009-09
    Erscheinungsland United States
    Dokumenttyp Letter
    ZDB-ID 120573-0
    ISSN 1523-1755 ; 0085-2538
    ISSN (online) 1523-1755
    ISSN 0085-2538
    DOI 10.1038/ki.2009.249
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang